Erik Abner
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Liver Disease Diagnosis and Treatment 5
-
- RNA modifications and cancer 2
- Co-authors
- Albert Jordan (2 shared papers)Tōnu Esko (11 shared papers)Benoît J. Arsenault (8 shared papers)Sébastien Thériault (8 shared papers)Patrick Mathieu (7 shared papers)Patricia L. Mitchell (6 shared papers)Hasanga D. Manikpurage (4 shared papers)Éloi Gagnon (5 shared papers)
- Journals
- Nature Communications (2 papers)iScience (1 paper)Journal of Translational Medicine (1 paper)Current Opinion in Virology (1 paper)EBioMedicine (1 paper)
- Partner nations
- EstoniaCanadaUnited States
In The Last Decade
Erik Abner
13 papers receiving 383 citations
Peers
Comparison fields: 5 of 65
- Virology 147
- Infectious Diseases 103
- Biological Psychiatry 8
- Immunology 66
- Epidemiology 81
Countries citing papers authored by Erik Abner
This map shows the geographic impact of Erik Abner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Abner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Abner more than expected).
Fields of papers citing papers by Erik Abner
This network shows the impact of papers produced by Erik Abner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Abner. The network helps show where Erik Abner may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Abner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 123 | |
| 2 | 2023 | 48 | |
| 3 | 2018 | 43 | |
| 4 | 2023 | 32 | |
| 5 | 2021 | 31 | |
| 6 | 2022 | 25 | |
| 7 | 2023 | 23 | |
| 8 | 2019 | 19 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2016 | 6 | |
| 13 | 2021 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2024 | 0 | |
| 16 | 2021 | 0 |
About Erik Abner
Erik Abner is a scholar working on Epidemiology, Molecular Biology, Genetics, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 388 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), HIV Research and Treatment (3 papers), Lipid metabolism and disorders (3 papers), Genetic Associations and Epidemiology (3 papers), HIV/AIDS drug development and treatment (3 papers), Alcohol Consumption and Health Effects (2 papers), Cancer-related molecular mechanisms research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Virology (147 citations), Infectious Diseases (103 citations), Biological Psychiatry (8 citations), Immunology (66 citations) and Epidemiology (81 citations). Erik Abner has collaborated with scholars based in Estonia, Canada and United States. Frequent co-authors include Albert Jordan, Tōnu Esko, Benoît J. Arsenault, Sébastien Thériault, Patrick Mathieu, Patricia L. Mitchell, Hasanga D. Manikpurage, Éloi Gagnon, Tokameh Mahmoudi and Nooshin Ghodsian. Their work appears in journals such as Nature Communications, iScience, Journal of Translational Medicine, Current Opinion in Virology and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.